![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMED4 |
Gene summary for TMED4 |
![]() |
Gene information | Species | Human | Gene symbol | TMED4 | Gene ID | 222068 |
Gene name | transmembrane p24 trafficking protein 4 | |
Gene Alias | ERS25 | |
Cytomap | 7p13 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q7Z7H5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
222068 | TMED4 | HTA11_2487_2000001011 | Human | Colorectum | SER | 5.05e-04 | 3.76e-01 | -0.1808 |
222068 | TMED4 | HTA11_1938_2000001011 | Human | Colorectum | AD | 6.23e-05 | 4.73e-01 | -0.0811 |
222068 | TMED4 | HTA11_78_2000001011 | Human | Colorectum | AD | 9.34e-06 | 4.37e-01 | -0.1088 |
222068 | TMED4 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.72e-16 | 5.89e-01 | -0.1954 |
222068 | TMED4 | HTA11_696_2000001011 | Human | Colorectum | AD | 3.13e-10 | 3.94e-01 | -0.1464 |
222068 | TMED4 | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.65e-07 | 4.46e-01 | -0.059 |
222068 | TMED4 | HTA11_546_2000001011 | Human | Colorectum | AD | 3.15e-02 | 3.07e-01 | -0.0842 |
222068 | TMED4 | HTA11_866_3004761011 | Human | Colorectum | AD | 7.38e-10 | 4.42e-01 | 0.096 |
222068 | TMED4 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 2.10e-07 | 3.91e-01 | 0.294 |
222068 | TMED4 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 7.93e-03 | 9.28e-01 | 0.3487 |
222068 | TMED4 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 4.23e-06 | 4.30e-01 | 0.281 |
222068 | TMED4 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 1.17e-14 | 5.83e-01 | 0.3859 |
222068 | TMED4 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.38e-08 | 4.06e-01 | 0.3005 |
222068 | TMED4 | A002-C-116 | Human | Colorectum | FAP | 2.00e-05 | -9.70e-02 | -0.0452 |
222068 | TMED4 | AEH-subject1 | Human | Endometrium | AEH | 1.80e-08 | -3.59e-01 | -0.3059 |
222068 | TMED4 | AEH-subject2 | Human | Endometrium | AEH | 8.06e-13 | -3.77e-01 | -0.2525 |
222068 | TMED4 | AEH-subject3 | Human | Endometrium | AEH | 3.11e-14 | -3.47e-01 | -0.2576 |
222068 | TMED4 | AEH-subject4 | Human | Endometrium | AEH | 2.17e-05 | -3.17e-01 | -0.2657 |
222068 | TMED4 | AEH-subject5 | Human | Endometrium | AEH | 8.71e-08 | -3.86e-01 | -0.2953 |
222068 | TMED4 | EEC-subject1 | Human | Endometrium | EEC | 2.53e-14 | -3.27e-01 | -0.2682 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004819316 | Oral cavity | LP | Golgi vesicle transport | 141/4623 | 296/18723 | 6.11e-18 | 1.06e-15 | 141 |
GO:004312316 | Oral cavity | LP | positive regulation of I-kappaB kinase/NF-kappaB signaling | 88/4623 | 186/18723 | 1.58e-11 | 1.13e-09 | 88 |
GO:000688814 | Oral cavity | LP | endoplasmic reticulum to Golgi vesicle-mediated transport | 67/4623 | 130/18723 | 3.74e-11 | 2.39e-09 | 67 |
GO:004312219 | Oral cavity | LP | regulation of I-kappaB kinase/NF-kappaB signaling | 103/4623 | 249/18723 | 4.48e-09 | 1.90e-07 | 103 |
GO:000724917 | Oral cavity | LP | I-kappaB kinase/NF-kappaB signaling | 110/4623 | 281/18723 | 4.94e-08 | 1.70e-06 | 110 |
GO:004819310 | Prostate | BPH | Golgi vesicle transport | 102/3107 | 296/18723 | 3.90e-14 | 4.56e-12 | 102 |
GO:00068887 | Prostate | BPH | endoplasmic reticulum to Golgi vesicle-mediated transport | 46/3107 | 130/18723 | 1.53e-07 | 3.53e-06 | 46 |
GO:00072499 | Prostate | BPH | I-kappaB kinase/NF-kappaB signaling | 79/3107 | 281/18723 | 7.61e-07 | 1.43e-05 | 79 |
GO:004312210 | Prostate | BPH | regulation of I-kappaB kinase/NF-kappaB signaling | 71/3107 | 249/18723 | 1.55e-06 | 2.64e-05 | 71 |
GO:00431239 | Prostate | BPH | positive regulation of I-kappaB kinase/NF-kappaB signaling | 54/3107 | 186/18723 | 1.50e-05 | 1.92e-04 | 54 |
GO:00070306 | Prostate | BPH | Golgi organization | 39/3107 | 157/18723 | 5.20e-03 | 2.43e-02 | 39 |
GO:004819314 | Prostate | Tumor | Golgi vesicle transport | 105/3246 | 296/18723 | 3.55e-14 | 4.33e-12 | 105 |
GO:000688813 | Prostate | Tumor | endoplasmic reticulum to Golgi vesicle-mediated transport | 49/3246 | 130/18723 | 2.49e-08 | 8.33e-07 | 49 |
GO:000724916 | Prostate | Tumor | I-kappaB kinase/NF-kappaB signaling | 77/3246 | 281/18723 | 1.55e-05 | 2.09e-04 | 77 |
GO:004312217 | Prostate | Tumor | regulation of I-kappaB kinase/NF-kappaB signaling | 69/3246 | 249/18723 | 2.83e-05 | 3.43e-04 | 69 |
GO:004312315 | Prostate | Tumor | positive regulation of I-kappaB kinase/NF-kappaB signaling | 53/3246 | 186/18723 | 1.04e-04 | 1.00e-03 | 53 |
GO:000703013 | Prostate | Tumor | Golgi organization | 40/3246 | 157/18723 | 6.33e-03 | 2.90e-02 | 40 |
GO:0048193110 | Skin | cSCC | Golgi vesicle transport | 153/4864 | 296/18723 | 1.85e-21 | 3.41e-19 | 153 |
GO:000688810 | Skin | cSCC | endoplasmic reticulum to Golgi vesicle-mediated transport | 73/4864 | 130/18723 | 2.60e-13 | 1.57e-11 | 73 |
GO:0043123110 | Skin | cSCC | positive regulation of I-kappaB kinase/NF-kappaB signaling | 84/4864 | 186/18723 | 1.09e-08 | 3.40e-07 | 84 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMED4 | SNV | Missense_Mutation | rs778062787 | c.643N>T | p.Arg215Cys | p.R215C | Q7Z7H5 | protein_coding | deleterious(0) | possibly_damaging(0.901) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMED4 | deletion | Frame_Shift_Del | novel | c.189_196delNNNNNNNN | p.Gln64GlyfsTer43 | p.Q64Gfs*43 | Q7Z7H5 | protein_coding | TCGA-BH-A0HB-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | docetaxel | SD | ||
TMED4 | SNV | Missense_Mutation | rs761985992 | c.443C>T | p.Ala148Val | p.A148V | Q7Z7H5 | protein_coding | deleterious(0.03) | possibly_damaging(0.6) | TCGA-AA-3710-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMED4 | SNV | Missense_Mutation | rs752654966 | c.554N>A | p.Arg185Gln | p.R185Q | Q7Z7H5 | protein_coding | deleterious(0.01) | probably_damaging(0.982) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMED4 | SNV | Missense_Mutation | rs545808069 | c.560N>T | p.Thr187Met | p.T187M | Q7Z7H5 | protein_coding | deleterious(0.02) | probably_damaging(0.93) | TCGA-AJ-A3BG-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | PD |
TMED4 | SNV | Missense_Mutation | novel | c.672N>T | p.Lys224Asn | p.K224N | Q7Z7H5 | protein_coding | deleterious(0) | probably_damaging(0.972) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMED4 | SNV | Missense_Mutation | c.304T>C | p.Phe102Leu | p.F102L | Q7Z7H5 | protein_coding | deleterious(0.03) | probably_damaging(0.942) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TMED4 | SNV | Missense_Mutation | novel | c.451N>T | p.Asp151Tyr | p.D151Y | Q7Z7H5 | protein_coding | deleterious(0) | benign(0.413) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMED4 | SNV | Missense_Mutation | c.639N>C | p.Gln213His | p.Q213H | Q7Z7H5 | protein_coding | deleterious(0) | probably_damaging(0.989) | TCGA-69-7978-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
TMED4 | SNV | Missense_Mutation | novel | c.475N>A | p.Arg159Ser | p.R159S | Q7Z7H5 | protein_coding | deleterious(0.03) | benign(0.233) | TCGA-18-3416-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |